Distribuzione geografica
Continente #
NA - Nord America 4.560
EU - Europa 4.063
AS - Asia 396
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 9.026
Nazione #
US - Stati Uniti d'America 4.554
PL - Polonia 2.816
IE - Irlanda 384
SE - Svezia 357
IT - Italia 235
HK - Hong Kong 143
DE - Germania 84
FI - Finlandia 84
CN - Cina 79
TR - Turchia 56
GB - Regno Unito 47
VN - Vietnam 43
IN - India 31
JO - Giordania 31
UA - Ucraina 23
SG - Singapore 10
BE - Belgio 8
BG - Bulgaria 5
CA - Canada 5
RU - Federazione Russa 5
ES - Italia 4
NL - Olanda 3
RO - Romania 3
AT - Austria 2
CH - Svizzera 2
CM - Camerun 2
EU - Europa 2
AU - Australia 1
BR - Brasile 1
FR - Francia 1
IR - Iran 1
JM - Giamaica 1
MM - Myanmar 1
MY - Malesia 1
SC - Seychelles 1
Totale 9.026
Città #
Warsaw 2.816
Fairfield 838
Ashburn 414
Woodbridge 405
Seattle 398
Dublin 384
Chandler 361
Cambridge 319
Houston 300
Wilmington 241
Ann Arbor 135
Altamura 122
Lawrence 122
Princeton 96
Boardman 74
Jacksonville 65
Hong Kong 64
Beijing 60
Medford 59
Florence 57
Buffalo 55
Izmir 54
San Diego 51
Boston 50
Dong Ket 39
New York 28
Norwalk 27
Pune 27
Phoenix 21
Guangzhou 12
Andover 11
Hillsboro 9
London 9
Brussels 8
Singapore 8
Falls Church 7
Rome 5
Sofia 5
Barcelona 4
Kilburn 4
Laurel 4
Milan 4
Shanghai 4
Toronto 4
Campi Bisenzio 3
Chiusi 3
Delhi 3
Moscow 3
Redwood City 3
Timisoara 3
Bern 2
Bremen 2
Cesena 2
Elice 2
Empoli 2
Fuzhou 2
Montevarchi 2
Old Bridge 2
Siena 2
Acton 1
Anghiari 1
Anzio 1
Arnsberg 1
Auburn Hills 1
Bologna 1
Carbonia 1
Centro 1
Chiswick 1
Cincinnati 1
Council Bluffs 1
Evanston 1
Frosinone 1
Grevenbroich 1
Islington 1
Kuala Lumpur 1
Melbourne 1
Montréal 1
Naaldwijk 1
Negrar 1
Norderstedt 1
Nürnberg 1
Ocho Rios 1
Prato 1
Prescot 1
Saint Petersburg 1
San Mateo 1
Senago 1
São Paulo 1
Tappahannock 1
Utrecht 1
Yangon 1
Totale 7.848
Nome #
Acute glucose dysmetabolism in the elderly with ST elevation myocardial infarction submitted to mechanical revascularization 213
Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes 213
Early invasive strategy and outcomes of non-ST-elevation acute coronary syndrome patients: is time really the major determinant? 213
Prevalence, predictors and prognostic significance of microalbuminuria in acute cardiac patients: a single center experience 211
In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes 210
Intraaortic Balloon Pump: Incidence and Predictors of Complications in the Florence Registry 209
Uric acid in the early risk stratification of ST-elevation myocardial infarction 209
Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction 207
Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role? 205
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 205
Continuous renal replacement therapy: should the cardiologist be able to manage it out of intensive care units? 204
ST-elevation myocardial infarction with preserved ejection fraction: The impact of worsening renal failure 198
Intra-aortic balloon pump in intensive cardiac care: a registry in Florence 196
The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia 195
Persistent and selective upregulation of renin-angiotensin system in circulating T lymphocytes in unstable angina. 193
Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes 193
STEMI patients--the more you bleed, the more you die: a comparison between classifications 192
Glycated hemoglobin in ST-elevation myocardial infarction without previously known diabetes: Its short and long term prognostic role 190
The prognostic impact of glycated hemoglobin in diabetic ST-elevation myocardial infarction 189
The impact of hypertension on patients with acute coronary syndromes 185
Lactate in the acute phase of ST-elevation myocardial infarction treated with mechanical revascularization A single-center experience 182
T lymphocyte based renin angiotensin system in obesity 139
Clinical and scintigraphic follow-up of ST-elevation myocardial infarction patients submitted to primary angioplasty and randomized to thrombus aspiration with Angiojet® or Export® 109
Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. 102
COmparison between COronary THrombus aspiration with Angiojet® or Export® catheter in patients with ST-elevation myocardial infarction submitted to primary angioplasty: The COCOTH Study 100
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 98
Effects of smoking in patients treated with cardiac resynchronization therapy 95
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 92
Cardiovascular effects of mild hypothermia in post-cardiac arrest patients by beat-to-beat monitoring. A single centre pilot study. 91
Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response 86
Dual antiplatelet therapy tailored on platelet function test after coronary stent implantation: a real-world experience 86
Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes: is dysrhythmia duration a parameter to focus on? 85
Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes. 84
Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: a preliminary report 82
Incidence of ultrasound-detected asymptomatic long-term central vein catheter-related thrombosis and fibrin sheath in cancer patients. 80
Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience 77
Impact of Hypertension History on Short and Long-Term Prognosis in Patients with Acute Myocardial Infarction Treated with Percutaneous Angioplasty: Comparison Between STEMI and NSTEMI. 77
Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study 75
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 75
A new post-PCI scoring system for in-hospital mortality in STEMI patients 74
Levosimendan produces an additional clinical and hemodynamic benefit in patients with decompensated heart failure successfully submitted to a fluid removal treatment 74
Microalbuminuria in Non-Diabetic Stemi : An Independent Predictor for Acute Kidney Injury 74
Nonthyroidal illness syndrome in ST-elevation myocardial infarction treated with mechanical revascularization. 73
Acute Insulin Resistance Assessed by the Homeostatic Model Assessment in Acute Coronary Syndromes Without Previously Known Diabetes. 72
Hemodynamic effects in patients with atrial fibrillation submitted to electrical cardioversion. 72
Prognostic role of glucose abnormalities in patients with ST-elevation myocardial infarction and mild renal impairment. 72
The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty 72
Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis 71
Usefulness of Hyponatremia in the Acute Phase of ST-Elevation Myocardial Infarction as a Marker of Severity. 71
Exaggerated myocardial oxLDL amount and LOX-1 receptor over-expression associated with coronary microvessel inflammation in unstable angina 71
Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction. 71
Congestive heart failure and decongestion ability of two different treatments: continuous renal replacement and diuretic therapy: experience of a cardiac step down unit. 71
NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers 71
Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients 71
Evaluation of acid-base balance in ST-elevation myocardial infarction in the early phase: a prognostic tool? 71
Microalbuminuria in hypertensive nondiabetic patients with ST elevation myocardial infarction 70
Clinical and prognostic significance of increased liver enzymes in ST-elevation myocardial infarction 69
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 69
A metabolic approach during normothermic regional perfusion in uncontrolled donors after circulatory death—A pilot study 69
Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred? 68
Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: A pilot study. 67
Mechanical ventilation in the early phase of ST elevation myocardial infarction treated with mechanical revascularization. 67
Endotoxin role in cardiogenic shock: A brief report. 65
Effects of two different treatments with continuous renal replacement therapy in patients with chronic renal dysfunction submitted to coronary invasive procedures. 63
Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers. 63
Procalcitonin as a Reliable Biomarker in Acute Coronary Syndromes: What Is Its Role? 62
Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients. 62
Dynamic behaviour of lactate values during mild hypothermia in patients with cardiac arrest. 60
Time of onset and outcome of cardiogenic shock in acute coronary syndromes. 60
The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. 59
Procalcitonin in acute cardiac patients 58
Cardiac cycle efficiency and dicrotic pressure variations: New parameters for fluid therapy: An observational study 58
Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data 54
Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. 53
Impact of age on the prognostic value of body mass index in ST-Elevation myocardial infarction. 53
The influence of renal function on the prognostic value of Nt-pro brain natriuretic peptide in St-elevation myocardial infarction. 53
Gender-related difference in ST-elevation myocardial infarction treated with primary angioplasty: a single-centre 6-year registry 52
Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study 51
Continuous recording of dicrotic and pulse pressures during head-up tilting test: the vasodepressive profile. Preliminary data. 50
Dynamic behavior of lactate values in venous-arterial extracorporeal membrane oxygenation for refractory cardiac arrest. 49
Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement 48
Age as a Prognostic Factor in Patients with Acute Coronary Syndrome undergoing Urgent/Emergency Cardiac Surgery 47
Predictors for in-hospital peak glycemia in STEMI patients without previously known diabetes 46
Comorbidities in stemi patients submitted to primary PCI: Temporal trends and impact on mortality: A 6-year single center experience. 44
Baroreflex function in vasodepressive syncope: detection of early impairment.Med Sci Monit. 2003 Mar;9(3):CR125-30. 43
T Cell-Based RAS Activity and Insulin Levels in Obese Subjects with Low Grade Inflammation 35
Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. 30
Malapposed Struts with Cre8, Biomatrix, and Xience Stents Assessed with OCT Immediately after Implantation and at 6-Month Follow-Up: Can the Different Biomechanical Characteristics of the Three Stents Impact on Struts Malapposition? 28
The impact of blood transfusion on short and long term prognosis in STEMI patients treated with primary percutaneous coronary intervention: A single center-experience. 27
Thrombus aspiration in elderly STEMI patients: A single center experience. 26
Predictors of early mortality in acute cardiac patients requiring renal replacement therapy: a single center experience. 24
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 15
Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure 14
Rotational mechanics of the left ventricle in AL amyloidosis 11
Totale 9.069
Categoria #
all - tutte 21.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.335

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019902 0 0 0 0 0 0 0 0 0 183 411 308
2019/20202.271 182 200 70 170 286 256 237 270 228 148 185 39
2020/20211.328 140 148 45 140 66 158 67 91 134 185 75 79
2021/2022682 24 49 79 23 28 31 27 52 33 34 113 189
2022/20231.622 165 310 59 106 136 295 231 86 155 16 53 10
2023/2024547 17 69 103 33 45 134 16 125 4 1 0 0
Totale 9.069